Why People with ADHD Get ME/CFS at Twice the Rate
This is the second in a series on the energy biology linking ADHD, autism, and ME/CFS. The first article presented the case for ADHD as a brain energy production deficit. This one answers the next question: why might that deficit make people vulnerable to ME/CFS?
1 The epidemiological signal
The ALSPAC birth cohort — one of the largest longitudinal studies in the world — followed 4,563 children from birth through age 18. The findings on neurodivergent traits and fatigue are striking (Quadt et al. 2024):
- ADHD traits at age 9 → OR = 2.18 (95% CI 1.33–3.56, p = 0.002) for chronic disabling fatigue at age 18 (note: the outcome measured was “chronic disabling fatigue,” not ME/CFS diagnosed by ICC or CCC criteria)
- Autism traits at age 7 → OR = 1.78 (95% CI 1.17–2.72, p = 0.004)
- IL-6 at age 9 mediated the pathway — independent of depression
The children who developed fatigue weren’t just neurodivergent. They were neurodivergent AND already inflamed. The inflammation was measurable a full nine years before the fatigue appeared.
2 The numbers in adult ME/CFS
Among adults with confirmed CFS (n = 158, single specialist clinic) (Sáez-Francàs et al. 2012):
- 29.7% had childhood ADHD — versus approximately 5–7% in the general population. A 5× enrichment.
- 20.9% still met adult ADHD criteria
- Those with comorbid ADHD had earlier CFS onset and worse prognosis
- ADHD severity and depressive symptoms were independent predictors of fatigue intensity
Caveats: this is a single-site specialist clinic sample (referral bias possible), ADHD was assessed retrospectively in adults recalling childhood symptoms (recall bias), and CFS was diagnosed by Fukuda criteria (broader than ICC/CCC). The enrichment may be smaller in community-based samples.
3 The metabolic reserve hypothesis
Think of brain energy production as a generator with a certain maximum output. Daily cognitive function requires some fraction of that output. The difference between what you need and what you can produce is your metabolic reserve — your buffer for when demands increase.
The ADHD brain already operates with 8.1% less global glucose metabolism (Zametkin et al. 1990) and documented prefrontal hypoperfusion (Berthier et al. 2025). Its generator is smaller. Its reserve is thinner.
Now add an immune trigger.
Fighting an infection is metabolically expensive. Cytokine production, lymphocyte proliferation, neuroinflammation — all consume energy. In someone with a large reserve, the system can sustain the immune response while repair processes operate in the background. Fatigue is temporary. Recovery follows.
In someone whose reserve was already marginal — whose brain was already running near capacity just to maintain attention — the same infection pushes the system below a critical threshold.
4 The two-hit threshold model
The transition from post-infectious fatigue to ME/CFS may occur at a specific threshold — though this remains a hypothesis, not a demonstrated biophysical event. The proposed mechanism: when mitochondrial damage from reactive oxygen species exceeds repair capacity, a self-sustaining cycle begins: damaged mitochondria produce more ROS, which damage more mitochondria, which produce more ROS. The system doesn’t spontaneously return to its pre-illness state.
Pre-existing metabolic reserve determines who crosses this threshold:
- High reserve (neurotypical, no metabolic risk factors): infection → transient fatigue → recovery
- Low reserve (ADHD, ASD, iron-deficient, hEDS): infection → threshold crossed → ME/CFS
The model predicts hysteresis — reversing the infection does not reverse ME/CFS, because the feed-forward damage cycle is now self-sustaining.
A simpler alternative explanation: the ALSPAC data showed IL-6 mediated the pathway. Chronic inflammation alone — without any “reserve” concept — could directly cause both neurodivergent traits and later fatigue vulnerability. The metabolic reserve model adds explanatory value only if correcting reserve deficits (iron, BH4, perfusion) prevents ME/CFS onset — a prediction that has not yet been tested.
5 The stimulant dissociation: consistent with the model
A 2025 PNAS survey of 3,925 ME/CFS patients found (Eckey et al. 2025):
- Stimulants improved brain fog in 77.1%
- Stimulants improved fatigue perception in 71.7%
- Stimulants had a net -1.5% effect on PEM
This dissociation is exactly what the metabolic reserve model predicts. Stimulants increase catecholamine efficiency — reducing the energy cost of each cognitive unit. They effectively increase cognitive headroom. But they do not increase mitochondrial maximum capacity. PEM is triggered by total metabolic expenditure exceeding production capacity, which stimulants do not change.
The improved cognition often leads to increased activity — spending the “savings” rather than banking them. The net result: better brain fog, unchanged or worse PEM.
6 Temporal precedence: ADHD comes first
A critical point often missed: the ALSPAC data shows ADHD traits preceding fatigue onset by nearly a decade (Quadt et al. 2024). This is not ME/CFS causing ADHD. It is ADHD marking the brains that will break first when an immune trigger arrives.
The 29.7% childhood ADHD prevalence in CFS cohorts tells the same story from the other direction (Sáez-Francàs et al. 2012): nearly a third of ME/CFS patients had a pre-existing energy deficit that was diagnosable as ADHD in childhood.
7 What is modifiable?
If the metabolic reserve hypothesis is correct, the predisposition is not purely genetic fate. Several components are modifiable:
Iron status. Ferritin below 30 ng/mL impairs both dopamine synthesis and mitochondrial function (DelRosso, Estrada Chaverri, and Ceballos Fuentes 2026). Correction is cheap and safe.
BH4 cofactor support. For GCH1 rs841 carriers (~4% of the population), BH4 supplementation or cofactor support (folinic acid, vitamin C, iron for recycling) may increase the reserve (Williams et al. 2025).
Cerebral perfusion. In patients with concurrent POTS/dysautonomia, standard perfusion management (compression, fluid/salt loading, reclined work positions) directly increases brain energy delivery.
No study has tested whether pre-emptive correction of these modifiable reserve reducers in neurodivergent patients reduces ME/CFS incidence after infection. The prediction is clear. The trial hasn’t been done.
Note: The above are research hypotheses about modifiable risk factors, not clinical recommendations. Discuss any intervention with a qualified clinician.
Part 2 of a series on the energy biology linking ADHD, autism, and ME/CFS.